Business Description
Captor Therapeutics SA
ISIN : PLCPTRT00014
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.9 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 3.5 | |||||
Beneish M-Score | -2.15 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -98 | |||||
3-Year EPS without NRI Growth Rate | -57.4 | |||||
3-Year FCF Growth Rate | -260 | |||||
Future 3-5Y Total Revenue Growth Rate | 103.62 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.09 | |||||
9-Day RSI | 37.06 | |||||
14-Day RSI | 39.47 | |||||
6-1 Month Momentum % | -1.25 | |||||
12-1 Month Momentum % | -21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.82 | |||||
Quick Ratio | 2.82 | |||||
Cash Ratio | 2.37 | |||||
Days Sales Outstanding | 81.96 | |||||
Days Payable | 307.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -10.66 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.97 | |||||
Operating Margin % | -255.81 | |||||
Net Margin % | -250.46 | |||||
FCF Margin % | -217.2 | |||||
ROE % | -84.58 | |||||
ROA % | -57.04 | |||||
ROIC % | -183.1 | |||||
ROC (Joel Greenblatt) % | -603.01 | |||||
ROCE % | -81.32 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 11.94 | |||||
PS Ratio | 19.37 | |||||
PB Ratio | 6.55 | |||||
Price-to-Tangible-Book | 6.72 | |||||
EV-to-EBIT | -6.08 | |||||
EV-to-EBITDA | -6.77 | |||||
EV-to-Revenue | 15.12 | |||||
EV-to-FCF | -7.51 | |||||
Price-to-Net-Current-Asset-Value | 8.24 | |||||
Price-to-Net-Cash | 11.23 | |||||
Earnings Yield (Greenblatt) % | -16.45 | |||||
FCF Yield % | -12.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Captor Therapeutics SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 18.64 | ||
EPS (TTM) (zł) | -9.04 | ||
Beta | 0.55 | ||
Volatility % | 48.19 | ||
14-Day RSI | 39.47 | ||
14-Day ATR (zł) | 3.127702 | ||
20-Day SMA (zł) | 74.53 | ||
12-1 Month Momentum % | -21 | ||
52-Week Range (zł) | 59 - 109.5 | ||
Shares Outstanding (Mil) | 4.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Captor Therapeutics SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Captor Therapeutics SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Captor Therapeutics SA Frequently Asked Questions
What is Captor Therapeutics SA(WAR:CTX)'s stock price today?
When is next earnings date of Captor Therapeutics SA(WAR:CTX)?
Does Captor Therapeutics SA(WAR:CTX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |